脂蛋白a在脑血管病中的研究新进展  

Research advances on lipoprotein(a)in cerebrovascular diseases

作　　者：郭怡兵 孟然[1] Guo Yibing;Meng Ran(Department of Neurology,Xuanwu Hospital,Capital Medical University,Beijing 100053,China)

机构地区：[1]首都医科大学宣武医院神经内科,北京100053

出　　处：《首都医科大学学报》2025年第1期71-75,共5页Journal of Capital Medical University

摘　　要：脂蛋白a[lipoprotein(a),Lp(a)]是血浆中一种具有特殊结构的脂蛋白颗粒。Lp(a)浓度升高与多种脑血管疾病密切相关,且多种靶向降低Lp(a)浓度的新型药物正处于临床试验阶段。本文综述了Lp(a)的结构、功能、遗传学特点、与脑血管病的相关性及其治疗的最新进展,旨在为Lp(a)的研究提供新方向,并为脑血管病的防治提供新思路。Lipoprotein(a)[Lp(a)]is a unique plasma lipoprotein particle with a distinct structure that has garnered significant research attention due to its strong association with various cerebrovascular diseases.Recent studies underscore elevated Lp(a)levels as a critical risk factor,with multiple Lp(a)-targeted therapies advancing through clinical trials.This review explores the structural,functional,and genetic features of Lp(a),its connection to cerebrovascular diseases,and the latest therapeutic strategies aimed at reducing its impact.By consolidating these advancements,we aim to provide new insights for Lp(a)-centered research and propose innovative approaches for cerebrovascular disease prevention and management.

关 键 词：脂蛋白A 脑血管病 临床研究进展 RNA靶向治疗 

分 类 号：R743[医药卫生—神经病学与精神病学]